536 related articles for article (PubMed ID: 22245967)
1. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.
Anczuków O; Rosenberg AZ; Akerman M; Das S; Zhan L; Karni R; Muthuswamy SK; Krainer AR
Nat Struct Mol Biol; 2012 Jan; 19(2):220-8. PubMed ID: 22245967
[TBL] [Abstract][Full Text] [Related]
2. RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation.
Shimoni-Sebag A; Lebenthal-Loinger I; Zender L; Karni R
Carcinogenesis; 2013 Nov; 34(11):2498-504. PubMed ID: 23843040
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
4. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
5. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
Gautrey HL; Tyson-Capper AJ
PLoS One; 2012; 7(12):e51497. PubMed ID: 23284704
[TBL] [Abstract][Full Text] [Related]
7. Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia.
Zou L; Zhang H; Du C; Liu X; Zhu S; Zhang W; Li Z; Gao C; Zhao X; Mei M; Bao S; Zheng H
J Hematol Oncol; 2012 Jul; 5():42. PubMed ID: 22839530
[TBL] [Abstract][Full Text] [Related]
8. Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD.
Leu S; Lin YM; Wu CH; Ouyang P
J Cell Sci; 2012 Jul; 125(Pt 13):3164-72. PubMed ID: 22454513
[TBL] [Abstract][Full Text] [Related]
9. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
Verduci L; Simili M; Rizzo M; Mercatanti A; Evangelista M; Mariani L; Rainaldi G; Pitto L
J Biol Chem; 2010 Dec; 285(50):39551-63. PubMed ID: 20923760
[TBL] [Abstract][Full Text] [Related]
12. RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.
Lee M; Dworkin AM; Gildea D; Trivedi NS; ; Moorhead GB; Crawford NP
Oncogene; 2014 Apr; 33(14):1818-27. PubMed ID: 23604122
[TBL] [Abstract][Full Text] [Related]
13. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.
Das S; Krainer AR
Mol Cancer Res; 2014 Sep; 12(9):1195-204. PubMed ID: 24807918
[TBL] [Abstract][Full Text] [Related]
14. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1.
Kanehiro Y; Todo K; Negishi M; Fukuoka J; Gan W; Hikasa T; Kaga Y; Takemoto M; Magari M; Li X; Manley JL; Ohmori H; Kanayama N
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1216-21. PubMed ID: 22232677
[TBL] [Abstract][Full Text] [Related]
16. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
[TBL] [Abstract][Full Text] [Related]
17. SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication.
Paz S; Lu ML; Takata H; Trautmann L; Caputi M
J Virol; 2015 Jun; 89(12):6275-86. PubMed ID: 25855733
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.
Comiskey DF; Jacob AG; Singh RK; Tapia-Santos AS; Chandler DS
Nucleic Acids Res; 2015 Apr; 43(8):4202-18. PubMed ID: 25845590
[TBL] [Abstract][Full Text] [Related]
19. Predicting sequence and structural specificities of RNA binding regions recognized by splicing factor SRSF1.
Wang X; Juan L; Lv J; Wang K; Sanford JR; Liu Y
BMC Genomics; 2011 Dec; 12 Suppl 5(Suppl 5):S8. PubMed ID: 22369183
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
